{"transactions":[{"id":4028291,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168911,"kind":"person","name":"Hagen Elisabeth","position":1,"cik":"0001721211","reported_name":"Hagen Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-01T00:15:10.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020."}],"balance_after":100000,"derivative":{"exercise_price":0.78,"expiration_date":"2023-02-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-014693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118014693/doc4.xml","form_type":"4"}},{"id":4173502,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168911,"kind":"person","name":"Hagen Elisabeth","position":1,"cik":"0001721211","reported_name":"Hagen Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-03T21:12:30.000Z","date":"2017-11-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019."}],"balance_after":200000,"derivative":{"exercise_price":1.105,"expiration_date":"2027-11-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-17-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117059249/doc4.xml","form_type":"4"}},{"id":4173501,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168911,"kind":"person","name":"Hagen Elisabeth","position":1,"cik":"0001721211","reported_name":"Hagen Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-03T21:12:30.000Z","date":"2017-11-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (the \"RSUs\").  The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-17-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117059249/doc4.xml","form_type":"4"}}]}